Skip to navigation

Investors

MS TSX: Quote: 0.37 | Change: +0.01 | 03.11.10 | 11:56:00 MST

Why Invest?

 

  • Dirucotide has blockbuster potential in a large underserved market
  • Potential near-term value creating milestones
  • Dirucotide is the only novel agent for secondary progressive multiple sclerosis (MS) in phase III trials
  • Dirucotide represents a new class of drug with potential significant advantages


Fill out the quick form to the right and we'll send you complete details on the BioMS investment opportunity

Get the Free Investment Package Now

Fill out the form below and the complete investment package will be mailed to you right away. We respect your privacy. Your information will never be shared with any 3rd party.

First name
Last name
Email Address
Address
City
State/Province
Country
Postal / Zip Code
Phone
Receive investor updates?
 
   

Investing Facts

 

  • Working Capital: $94.0 million (as of September 30, 2008)
  • Shares Outstanding: 91,086,323 (as of September 30, 2008)
  • 52-week Range: $1.70-$4.39 (as of August 15, 2008)
  • Fiscal Year-End: December 31st
  • Listed on the Toronto Stock Exchange (TSX): Stock Symbol "MS"